Saudi Arabia’s $600 billion U.S. investment commitment is one factor that could drive upside in 2026, though the outlook for ...

AMD's current share price undervalues its long-term prospects, especially with momentum in the Data Center, Client, and ...

Fintel reports that on May 27, 2025, HSBC upgraded their outlook for Advanced Micro Devices (NasdaqGS:AMD) from Reduce to ...

Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced that it has ...

Nvidia faces major risks from escalating US-China trade tensions, with Chinese competitors rapidly gaining market share. Read ...

The gross proceeds from the offering, before deducting the underwriting discounts and commissions and offering expenses payable by Outlook Therapeutics are expected to be approximately $13.0 million.

ISELIN, N.J., May 23, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics ... the treatment of wet age-related macular degeneration (wet AMD), today announce ISELIN, N.J., Feb. 28, 2025 (GLOBE NEWSWIRE ...

Wedbush expects significant value to be unlocked through Tesla’s full self-driving (FSD) technology and the rollout of its ...

AMD (NASDAQ: AMD) isn't a bad company by any means, but if there was ever a company that could fit the saying, "always a ...

Advanced Micro Devices (NASDAQ: AMD) is an important player in the global semiconductor industry as its chips power multiple ...

Shares of Advanced Micro Devices (NASDAQ:AMD) have bounced back nicely since hitting their year-to-date low of $78.21 on April 8. Since bottoming, the stock is now up 46.70%, including a 34.16% ...